| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 750,433 | 783,708 | 742,251 | 861,793 | | Cost of Revenue | 505,647 | 554,575 | 573,526 | 627,148 | | | Gross Profit | 244,786 | 229,133 | 168,725 | 234,645 | | | Operating Expenses | | Research Development | 26,390 | 27,105 | 28,962 | 30,992 | | Selling General and Administrative | 103,197 | 98,951 | 101,205 | 112,001 | | Non Recurring | 3,207 | 8,117 | 8,703 | 409,569 | | Others | 20,824 | 20,825 | 20,824 | 24,465 | | | | Total Operating Expenses | 153,618 | 154,998 | 159,694 | 577,027 | | | | Operating Income or Loss | 91,168 | 74,135 | 9,031 | (342,382) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,194) | 525 | (8,551) | 2,420 | | Earnings Before Interest And Taxes | 89,974 | 74,660 | 480 | (339,962) | | Interest Expense | 25,655 | 43,183 | 30,627 | 36,645 | | Income Before Tax | 64,319 | 31,477 | (30,147) | (376,607) | | Income Tax Expense | 18,492 | 16,050 | (9,625) | (34,231) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 45,827 | 15,427 | (20,522) | (342,376) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 45,827 | 15,427 | (20,522) | (342,376) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $45,827 | $15,427 | ($20,522) | ($342,376) |
|
0.29% Nasdaq 
Income Statement
